Daniel Bandeira

Daniel Bandeira

Auto-generated profile, based on publicly available information

Daniel Bandeira

Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2025 in Journal of the Society for Cardiovascular Angiography & Interventions
Verified
Journal Article
Open access
RPRicardo Petraco
Ricardo Petraco
RBRahul Bahl
Rahul Bahl
GAGuilherme Almeida
Guilherme Almeida
DBDaniel Bandeira
Daniel Bandeira
HSHenry Seligman
Henry Seligman
DCDaniel Chamié
Daniel Chamié

14 January 2025 in Journal of the Society for Cardiovascular Angiography & Interventions
Verified
Journal Article
Open access
DBDaniel Bandeira
Daniel Bandeira
SPSteven E. Pfau
Steven E. Pfau
DCDaniel Chamié
Daniel Chamié

27 January 2022 in Journal of Transcatheter Interventions
Verified
Journal Article
Open access
PDF file
FSFernando Mendes Sant’anna
Fernando Mendes Sant’anna
DBDaniel Gustavo Sabino Ferreira Bandeira
Daniel Gustavo Sabino Ferreira Bandeira
LSLucas Bonacossa Sant’anna
Lucas Bonacossa Sant’anna
BCBruno Casagrande
Bruno Casagrande
JMJúlio de Paiva Maia
Júlio de Paiva Maia
DCDaniel Chamié
Daniel Chamié
Invasive physiological assessment of the coronary circulation has emerged in recent years as a valuable diagnostic approach in the management of patients with chronic coronary syndrome, overcoming important limitations such as evaluating function from the anatomy and the low spatial resolution associated with angiography or non-invasive tests. The value of hyperemic flow measurements to estimate the functional relevance of coronary stenoses is supported by many studies. The aim of this paper is to review the physiological bases, clinical applications and limitations of myocardial fractional flow reserve, the main index used in the invasive functional assessment of the coronary circulation.

4 August 2026 in ABC Imagem Cardiovascular
Verified
Journal Article
Open access
PDF file
MGMatheus Sacco Gomes
Matheus Sacco Gomes
ACAmanda Raquel Costa Cruz
Amanda Raquel Costa Cruz
BMBruno Leal Martins
Bruno Leal Martins
MCMario Henrique Caliano
Mario Henrique Caliano
PMPatricia de Souza Magalhães
Patricia de Souza Magalhães
MCMarinella Patrizia Centemero
Marinella Patrizia Centemero
Introdução As anomalias coronárias congênitas constituem um grupo heterogêneo de variações anatômicas, geralmente identificadas de forma incidental

3 September 2026 in ABC Imagem Cardiovascular
Verified
Journal Article
Open access
PDF file
MGMatheus Sacco Gomes
Matheus Sacco Gomes
ACAmanda Raquel Costa Cruz
Amanda Raquel Costa Cruz
BMBruno Leal Martins
Bruno Leal Martins
MCMario Henrique Caliano
Mario Henrique Caliano
PMPatricia de Souza Magalhães
Patricia de Souza Magalhães
MCMarinella Patrizia Centemero
Marinella Patrizia Centemero
Introduction Congenital coronary anomalies comprise a heterogeneous group of anatomical variations, most often identified incidentally during non-invasive

31 July 2025 in Journal of the Society for Cardiovascular Angiography & Interventions
Verified
Journal Article
Open access
RBRahul Bahl
Rahul Bahl
SMSamay Mehta
Samay Mehta
HSHenry Seligman
Henry Seligman
CRChristopher A. Rajkumar
Christopher A. Rajkumar
SGSuraya Gafore
Suraya Gafore
RPRicardo Petraco
Ricardo Petraco
Coronary microvascular function assessment with invasive Doppler-derived coronary flow reserve (CFR) has challenges related to Doppler signal quality, limiting clinical adoption. We investigated whether the use of ultrasound microbubble contrast agents can improve coronary flow signals and reduce measurement variability during invasive CFR measurement. Participants underwent assessment of coronary flow velocity using a Doppler sensor-tipped coronary wire. Baseline signal quality was determined by expert clinicians, and signals were categorized into good or poor quality. Doppler quality was then assessed at predetermined time periods after administration of SonoVue (Bracco): baseline, first pass, and subsequent discrete 20-second time periods, following this up to 260 seconds after first pass. For each time period, several parameters were assessed: signal-to-noise ratio, Doppler envelope quality (analyzed by a previously validated artificial intelligence–based score), and the coefficient of variation of tracked flow velocity. Fifteen cases were included. In the group with poor quality baseline Doppler signal (N = 10), signal-to-noise ratio, Doppler envelope quality score, and coefficient of variation significantly improved with microbubble contrast (signal-to-noise ratio: P < .05 for all periods after first pass; Doppler envelope quality score: P < .05 for all periods; coefficient of variation: P < .05 for all periods). In the group with a good quality baseline Doppler signal (N = 5), there were no changes in these parameters. Microbubble administration did not cause significant coronary hyperemia (P = .875 when compared to baseline). Ultrasound microbubble contrast agents can enhance Doppler signal quality during invasive CFR measurements. These agents could be used to improve the reliability of flow measurements in clinical practice and facilitate the adoption of coronary microvascular assessment.